Sexual activity in implantable cardioverter defibrillator patients included in cardiac rehabilitation

被引:2
|
作者
Maria Maroto-Montero, Jose [1 ,2 ]
Maroto-de Pablo, Marta [2 ,3 ]
Starling-Duarte, Juan [1 ]
Prados-Cabiedas, Carolina [4 ]
Villahoz-Garcia, Carmen [2 ]
Cabrero-Soblechero, Lara [2 ]
Sanchez-Corbal, Marta [1 ]
Valverde-dos Anjos, Belen [1 ]
Munoz-Sanjuan, Yesica [1 ]
机构
[1] Hosp Vithas Nuestra Senora de Fatima, Unidad Rehabil Cardiaca, Vigo, Pontevedra, Spain
[2] Residencia Socio Sanitaria, Unidad Rehabil Cardiaca Ecoplar, Madrid, Spain
[3] Univ Autonoma, Fac Med, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Serv Cardiol, Unidad Rehabil Cardiaca, Madrid, Spain
来源
ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2018年 / 88卷 / 02期
关键词
Implantable cardioverter defibrillator; Sexual activity; Cardiac rehabilitation; Spain;
D O I
10.1016/j.acmx.2017.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To analyse the effects of a Cardiac Rehabilitation Program (CRP) on quality of life and sexual activity levels in patients with implantable cardioverter defibrillators (ICD). Method: A total of 25 patients (22 men and 3 women) were included in a study that consisted of the analysis of any defibrillator discharges, their repercussion on the couple, and the effects of CRP on physical and psychological aspects, and on sexual activity (SA). Results: The mean age of the patients was 55 years (22 to 79). Initially, fear for device discharges was present in all patients. On arrival, 14 patients (56%) did not have any SA: 2 with ages of 69 and 79 years; one woman due to severe anxiety; an alcoholic man, and 10 because the ICD had been implanted less than 1 month before. Nine men and two women had restarted SA: 5 of them 5-52 months after the implantation, and the other 6, 30 days after implantation of the ICD while attending the CRP. At the end of the study, 21 patients had regained SA. Two men had clinical signs of depression and anxiety, with one requiring specialised treatment. Functional capacity improved significantly, 6.5 +/- 3.0 METs at the beginning of the program and 9.2 +/- 3.3 METs at the end, with a P < .005. There was only one inappropriate discharge. Conclusions: Discharges caused by newest devices have dropped significantly. This fact, together with the action of CRP at physical, psychological, and informative levels, makes it possible to control the dysfunctions in the quality of life and sexuality in patients. (C) 2017 Institute Nacional de Cardiologi'a Ignacio Chavez. Published by Masson Doyma Mexico S.A. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 50 条
  • [21] Analysis of implantable cardioverter defibrillator signals for non conventional cardiac electrical activity characterization
    Casaleggio, Aldo
    Rossi, Paolo
    Faini, Andrea
    Guidotto, Tiziana
    Malavasi, Vincenzo
    Musso, Giacomo
    Sartori, Giuseppe
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2006, 44 (1-2) : 45 - 53
  • [22] Analysis of implantable cardioverter defibrillator signals for non conventional cardiac electrical activity characterization
    Aldo Casaleggio
    Paolo Rossi
    Andrea Faini
    Tiziana Guidotto
    Vincenzo Malavasi
    Giacomo Musso
    Giuseppe Sartori
    Medical and Biological Engineering and Computing, 2006, 44 : 45 - 53
  • [23] Pacemaker, cardiac resynchonisation, implantable cardioverter/defibrillator, event monitoring
    Klein, N.
    Klein, M.
    Pfeiffer, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (49) : 2526 - 2529
  • [24] Prevention of sudden cardiac death by the implantable cardioverter-defibrillator
    Hindricks, Gerhard
    Lenarczyk, Radoslaw
    Kalarus, Zbigniew
    Doering, Michael
    Shamloo, Alireza Sepehri
    Dagres, Nikolaos
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (12): : 764 - 770
  • [25] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [26] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
    Cavalcanti, Rafael
    Aboul-Hosn, Nael
    Morales, Gustavo
    Abdel-Latif, Ahmed
    ANGIOLOGY, 2018, 69 (04) : 297 - 302
  • [27] Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis
    Hamon, David
    Algalarrondo, Vincent
    Gandjbakhch, Estelle
    Extramiana, Fabrice
    Marijon, Eloi
    Elbaz, Nathalie
    Selhane, Dounia
    Dubois-Rande, Jean-Luc
    Teiger, Emmanuel
    Plante-Bordeneuve, Violaine
    Damy, Thibaud
    Lellouche, Nicolas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 562 - 568
  • [28] Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter-defibrillator implantation
    Ahmed, Raheel
    Jamil, Yumna
    Ramphul, Kamleshun
    Mactaggart, Sebastian
    Bilal, Maham
    Singh Dulay, Mansimran
    Shi, Rui
    Azzu, Alessia
    Okafor, Joseph
    Memon, Rahat A.
    Sakthivel, Hemamalini
    Khattar, Rajdeep
    Wells, Athol Umfrey
    Baksi, John Arun
    Wechalekar, Kshama
    Kouranos, Vasilis
    Chahal, Anwar
    Sharma, Rakesh
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, : 1394 - 1403
  • [29] Exploding Implantable Cardioverter Defibrillator
    Sweeney, MO
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (12) : 1422 - 1424
  • [30] The Subcutaneous Implantable Cardioverter Defibrillator
    Mangels, Daniel
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2016, 24 (05) : 248 - 255